Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,936 | 66,769 | 1,579 | 16,927 | 463 |
| Gross Profit | 1,936 | 66,769 | 1,579 | 16,927 | 463 |
| Operating Expenses | 168,691 | 178,275 | 157,210 | 155,967 | 141,264 |
| Operating Income | -166,755 | -111,506 | -155,631 | -139,040 | -140,801 |
| Interest Expense | 26,322 | 24,265 | 22,946 | 22,594 | 22,298 |
| Other Income | -113,101 | 1,401 | 17,201 | 11,614 | 2,554 |
| Pre-tax Income | -306,178 | -134,370 | -161,376 | -150,020 | -160,545 |
| Net Income Continuous | -306,178 | -134,370 | -161,376 | -150,020 | -160,545 |
| Net Income | $-306,178 | $-134,370 | $-161,376 | $-150,020 | $-160,545 |
| EPS Basic Total Ops | -2.55 | -1.12 | -1.36 | -1.26 | -1.36 |
| EPS Basic Continuous Ops | -2.55 | -1.12 | -1.36 | -1.26 | -1.36 |
| EPS Diluted Total Ops | -2.55 | -1.12 | -1.36 | -1.26 | -1.36 |
| EPS Diluted Continuous Ops | -2.55 | -1.12 | -1.36 | -1.26 | -1.36 |
| EPS Diluted Before Non-Recurring Items | -1.54 | -1.12 | -1.36 | -1.26 | -1.36 |
| EBITDA(a) | $-164,076 | $-109,221 | $-153,331 | $-136,657 | $-138,390 |